Patient Guide: A First-in-human Study to Learn How Safe the Study Treatment BAY2862789 is, to Find the Best Dose, How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, and How it Acts on Different Tumors in Participants With Advanced Solid Tumors

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 18 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05858164
Status: ACTIVE_NOT_RECRUITING
Condition: Carcinoma, Non-Small-Cell Lung
Phase: PHASE1

Where You Can Participate

This study is available at 18 locations across the country.

Top locations include:
  • • Celebration, Florida
  • • Detroit, Michigan
  • • Jackson, Mississippi
  • • And 15 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A First-in-human Study to Learn How Safe the Study Treatment BAY2862789 is, to Find the Best Dose, How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, and How it Acts on Different Tumors in Participants With Advanced Solid Tumors - Join Clinical Trial NCTNCT05858164

How to Join This Clinical Trial - NCTNCT05858164

Learn how to participate in this PHASE1 trial studying an investigational therapy for Carcinoma, Non-Small-Cell Lung. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Carcinoma, Non-Small-Cell Lung. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Carcinoma, Non-Small-Cell Lung
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05858164 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 18 locations. Find a study site near you:

Clinical Research Site

Celebration, Florida 34747 - United States

Status: Contact for availability

Clinical Research Site

Detroit, Michigan 48202 - United States

Status: Contact for availability

Clinical Research Site

Jackson, Mississippi 39216 - United States

Status: Contact for availability

Clinical Research Site

Houston, Texas 77030 - United States

Status: Contact for availability

Clinical Research Site

San Antonio, Texas 78229 - United States

Status: Contact for availability

Clinical Research Site

Darlinghurst, New South Wales 2010 - Australia

Status: Contact for availability

Clinical Research Site

QLD, Queensland 4102 - Australia

Status: Contact for availability

Clinical Research Site

Wuhan, Hubei 430030 - China

Status: Contact for availability

Clinical Research Site

Changchun, Jilin 130000 - China

Status: Contact for availability

Clinical Research Site

Jerusalem, 9112001 - Israel

Status: Contact for availability

And 8 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Carcinoma, Non-Small-Cell Lung:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships